Acute Myeloid Leukemia — Trials

Acute Myeloid Leukemia — Trials · CancerIndex

Clinical trials

Registered studies

2,962 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 789
Recruiting: 466
Ph III recruiting: 45
Growth YoY: +5%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 38.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (534)

clinicaltrialsPublishedShowing 1–15 of 15 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07773909	Venetoclax With Hypomethylating Agents in Newly Diagnosed AML Unfit for Intensive Chemotherapy	completed	Phase 4	24	Bangabandhu Sheikh Mujib Medical University, Dhaka, BangladeshOTHER	1	Aug 21, 2026	clinicaltrials
NCT02926586	Fludarabine and Cytarabine Versus High-dose Cytarabine for CBF-AML	completed	Phase 4	68	Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineOTHER	1	Oct 1, 2024